77015-6

LOINC 2.82

Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative

Fet Ts 18 risk Plas.cfDNA Ql

Definition

  • This term was created for, but is not limited in use to, Sequenom Laboratories' VisibiliT Trisomy 18 test, which analyzes circulating cell-free DNA extracted from maternal plasma using whole genome sequencing to determine the risk for fetal chromosome 18 aneuploidy. VisibiliT is indicated for use in pregnant women with average risk for fetal chromosomal aneuploidy.

Component

  • Fetal trisomy 18 risk

Specimen / system

  • Plas.cfDNA

Class

  • MOLPATH.TRISOMY

Property

  • Imp

Scale

  • Ord

Method

  • Sequencing

Related names

  • Edward syndrome; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Next generation sequencing; NGS; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; T18 risk; Ts; Ts 18 risk

Index terms

  • Edward syndrome
  • Genetics
  • Heredity
  • Heritable
  • high-throughput sequencing
  • HTS
  • Impression
  • Impression/interpretation of study
  • Impressions
  • Inherited
  • Interp
  • Interpretation
  • Molecular pathology
  • MOLPATH
  • MOLPATH.TRISOMY
  • Next generation sequencing
  • NGS
  • Ordinal
  • Pl
  • Plasma
  • Plsm
  • Point in time
  • QL
  • Qual
  • Qualitative
  • Random
  • Screen
  • T18 risk
  • Ts
  • Ts 18 risk